Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Maravai Lifesciences Holdings' FCF Payout Ratio history runs 5 years deep, the most recent figure standing at 0.01 for Q4 2024.

• In Q4 2024, FCF Payout Ratio changed N/A year-over-year to 0.01; the TTM figure through Sep 2025 stood at 0.02 (down 256.43% YoY), while the FY2024 annual figure was 0.1, up 31.72% from the prior year.
• FCF Payout Ratio for Q4 2024 stood at 0.01, down from 0.11 in the prior quarter.
• The five-year high for FCF Payout Ratio was 1.7 in Q4 2020, with the low at 0.22 in Q2 2023.
• The 5-year median for FCF Payout Ratio is 0.25 (2022), against an average of 0.39.
• The sharpest annual moves came in 2021 and 2023: FCF Payout Ratio soared 15966.18% in 2021, then sank 184.44% in 2023.
• Maravai Lifesciences Holdings' FCF Payout Ratio stood at 1.7 in 2020, then declined by 1.4% to 1.67 in 2021, then sank by 82.96% to 0.28 in 2022, then slumped by 178.09% to 0.22 in 2023, then soared by 94.65% to 0.01 in 2024.
• Business Quant data shows MRVI's FCF Payout Ratio at 0.01 in Q4 2024, 0.11 in Q2 2024, and 0.22 in Q2 2023.